Marotta Asset Management Novartis Ag Transaction History

Marotta Asset Management

$478 Million
Q4 2024

A detailed history of Marotta Asset Management transactions in Novartis Ag stock. As of the latest transaction made, Marotta Asset Management holds 7,003 shares of NVS stock, worth $785,246. This represents 0.14% of its overall portfolio holdings.

Number of Shares

7,003

Previous 7,270 3.67%

Holding current value

$785,246

Previous $836,000 18.54%

% of portfolio

0.14%

Previous 0.16%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 10, 2025	SELL	$96.78 - $117.18 $25,840 - $31,287	-267 Reduced 3.67%	7,003 $681,000
Q3 2024 Oct 03, 2024	SELL	$106.13 - $120.89 $11,462 - $13,056	-108 Reduced 1.46%	7,270 $836,000
Q2 2024 Jul 17, 2024	SELL	$92.57 - $107.37 $10,552 - $12,240	-114 Reduced 1.52%	7,378 $785,000
Q1 2024 Apr 02, 2024	SELL	$95.27 - $108.47 $6,764 - $7,701	-71 Reduced 0.94%	7,492 $724,000
Q4 2023 Jan 03, 2024	SELL	$92.27 - $101.54 $13,102 - $14,418	-142 Reduced 1.84%	7,563 $763,000
Q3 2023 Oct 11, 2023	SELL	$94.73 - $105.13 $3,410 - $3,784	-36 Reduced 0.47%	7,705 $784,000
Q2 2023 Jul 05, 2023	SELL	$92.52 - $104.91 $13,045 - $14,792	-141 Reduced 1.79%	7,741 $781,000
Q4 2022 Jan 03, 2023	SELL	$75.55 - $92.52 $9,217 - $11,287	-122 Reduced 1.52%	7,882 $0
Q3 2022 Oct 11, 2022	SELL	$74.61 - $87.26 $7,834 - $9,162	-105 Reduced 1.29%	8,004 $608,000
Q1 2022 Apr 08, 2022	BUY	$80.11 - $90.62 $3,524 - $3,987	44 Added 0.55%	8,109 $711,000
Q4 2021 Jan 13, 2022	BUY	$79.7 - $88.13 $13,549 - $14,982	170 Added 2.15%	8,065 $705,000
Q3 2021 Oct 21, 2021	BUY	$81.78 - $95.14 $9,404 - $10,941	115 Added 1.48%	7,895 $645,000
Q2 2021 Jul 09, 2021	BUY	$85.24 - $94.15 $97,344 - $107,519	1,142 Added 17.2%	7,780 $709,000
Q1 2021 Apr 09, 2021	BUY	$83.5 - $98.47 $554,273 - $653,643	6,638 New	6,638 $567,000

Others Institutions Holding NVS

# of Institutions

1,478

Shares Held

134M

Call Options Held

1.31M

Put Options Held

1.56M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $241B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marotta Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Marotta Asset Management with notifications on news.

Account

Marotta Asset Management Novartis Ag Transaction History